Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Therapy in HIV-1 Infected Children”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Testing effectiveness (Phase 2)WithdrawnNCT00614640
What this trial is testing

Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT01771562
What this trial is testing

Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent

Who this might be right for
HIV-1
ANRS, Emerging Infectious Diseases 330
Not applicableUnknownNCT02674867
What this trial is testing

CLEAC (Comparison of Late Versus Early Antiretroviral Therapy in HIV-infected Children)

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 80
Not applicableStudy completedNCT04233242
What this trial is testing

Genotype-Informed Versus Empiric Management of VirEmia

Who this might be right for
HIV-1-infection
Swiss Tropical & Public Health Institute 286
Not applicableStudy completedNCT02063880
What this trial is testing

Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)

Who this might be right for
Human Immunodeficiency VirusImmune Reconstitution Inflammatory Syndrome
University of Washington 183
Testing effectiveness (Phase 2)Study completedNCT00887120
What this trial is testing

Dose Reduction of Lopinavir in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Not applicableStudy completedNCT02058927
What this trial is testing

Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia

Who this might be right for
Measles
University of North Carolina, Chapel Hill 203
Testing effectiveness (Phase 2)Study completedNCT00000872
What this trial is testing

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Early research (Phase 1)Study completedNCT01973439
What this trial is testing

PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months

Who this might be right for
HIV Infection
PENTA Foundation 23
Testing effectiveness (Phase 2)UnknownNCT00791700
What this trial is testing

An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children

Who this might be right for
Human Immunodeficiency Virus
ViiV Healthcare 103
Large-scale testing (Phase 3)Study completedNCT01196195
What this trial is testing

KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)

Who this might be right for
Antiretroviral Therapy in HIV-1 Infected Children
PENTA Foundation 173
Large-scale testing (Phase 3)Study completedNCT01854775
What this trial is testing

Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children

Who this might be right for
Acquired Immune Deficiency Syndrome (AIDS)HIV Infections
Gilead Sciences 129
Testing effectiveness (Phase 2)Study completedNCT00665847
What this trial is testing

TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents

Who this might be right for
HIV-1
Tibotec Pharmaceuticals, Ireland 103
Large-scale testing (Phase 3)Study completedNCT02383108
What this trial is testing

Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children

Who this might be right for
HIV Infection
PENTA Foundation 318
Testing effectiveness (Phase 2)Study completedNCT00001688
What this trial is testing

A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT00122538
What this trial is testing

Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)

Who this might be right for
HIV InfectionsAIDS
French National Agency for Research on AIDS and Viral Hepatitis 52
Testing effectiveness (Phase 2)Study completedNCT01504841
What this trial is testing

Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 26
Testing effectiveness (Phase 2)Study completedNCT01717287
What this trial is testing

The Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 32
Large-scale testing (Phase 3)Study completedNCT00039741
What this trial is testing

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 266
Large-scale testing (Phase 3)Study completedNCT00528957
What this trial is testing

Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children

Who this might be right for
HIV Infections
Gilead Sciences 97
Next Page